GlassScriptPhysician profile
Heather D Rogers
NPI 1376717363
$2,975.66
in general payments reported to CMS, 2019-2025
20 companies · $720 in 2025
The $720 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $108 · 2021: $86.90 · 2022: $653 · 2023: $206 · 2024: $730 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.21 | 2021-2025 | Skyrizi |
| Galderma Laboratories, L.P. | $450.15 | 2019-2024 | |
| Genzyme Corporation | $400.60 | 2022-2025 | |
| Allergan, INC. | $200.59 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $171.54 | 2023-2025 | Zoryve |
| Stryker Corporation | $169.51 | 2022 | |
| Biofrontera INC. | $151.00 | 2019 | |
| Revance Therapeutics, INC. | $150.94 | 2024-2025 | Daxxify |
| Incyte Corporation | $136.88 | 2023-2025 | Opzelura |
| Janssen Biotech, INC. | $121.79 | 2022 | |
| Endo Pharmaceuticals INC. | $108.95 | 2019 | |
| Leo Pharma INC. | $79.80 | 2023 | Adbry |
| Sun Pharmaceutical Industries INC. | $38.91 | 2025 | |
| Organogenesis INC. | $31.59 | 2024 | Affinity |
| Lilly USA, LLC | $31.33 | 2025 | Taltz, Ebglyss |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $30.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.10 | 2023-2025 | |
| Axogen | $26.14 | 2022 | |
| Ucb, INC. | $13.66 | 2024 | Bimzelx |
| Organon LLC | $4.64 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.